GLP1R and Parkinson disease: Dysfunction in the bidirectional interactions between enteroendocrine cells and the hormone glucagon-like peptide-1 (GLP-1) that they secrete has been linked to PD pathogenesis, potentially involving links to SCFA metabolism [139, 140].